Report of Foreign Issuer (6-k)
February 16 2017 - 7:06AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES
EXCHANGE ACT OF 1934
For
the month of February 2017
Commission
File Number 001-37381
MEDIGUS
LTD.
(Translation of registrant’s name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY
NOTE
On
February 16, 2017, Medigus Ltd. issued a press release titled: “Medigus Receives Approval for Commencement of the First
Multi-Center MUSE™ Clinical Study from CFDA in China.” A copy of this press release is furnished herewith as exhibit
99.1.
This
Form 6-K is incorporated by reference into the Company’s Registration Statement on Form F-3 filed with the Securities and
Exchange Commission on August 24, 2016 (Registration No. 333-213280) and its Registration Statement on Form S-8 filed with the
Securities and Exchange Commission on September 9, 2015 (Registration No. 333-206803).
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
MEDIGUS
LTD.
|
|
|
|
Date:
February 16, 2017
|
By:
|
/s/
Oded Yatzkan
|
|
|
Oded
Yatzkan
|
|
|
Chief
Financial Officer
|
EXHIBIT
INDEX
Exhibit
|
|
Description
|
|
|
|
99.1
|
|
Press
release titled: “Medigus Receives Approval for Commencement of the First Multi-Center MUSE™ Clinical Study from
CFDA in China,” dated February 16, 2017.
|
4
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2023 to Apr 2024